Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T45597 | Target Info | |||
| Target Name | Ribosomal protein S6 kinase (S6K) | ||||
| Synonyms | Ribosomal s6 kinase | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | NO-GeName | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US7435819 | ||||
| Title | 4,5,6,7-Tetrahydro-[1,2]Dithiolo[4,3-C]Pyridine-3-Thione Compounds. | ||||
| Representative Drug(s) | D0M0AK | Drug Info | N.A. | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Ribosomal S6 kinase (RSK) modulators: a patent review.Expert Opin Ther Pat. 2016 Sep;26(9):1061-78. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.